Results 241 to 250 of about 202,668 (261)

Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan

Annals of Oncology, 2007
Y Nishiwaki, Y Ariyoshi, S Negoro
exaly  

Cisplatin see Bleomycin/cisplatin/etoposide

Reactions, 1989
openaire   +1 more source

Oxaliplatin for the treatment of cisplatin-resistant cancer: A systematic review

Cancer Treatment Reviews, 2007
Nick Pavlakis, Ross Davey
exaly  

Cisplatin see Bleomycin/cisplatin/etoposide

Reactions Weekly, 1991
openaire   +1 more source

Apoptosis by cisplatin requires p53 mediated p38α MAPK activation through ROS generation

Apoptosis: an International Journal on Programmed Cell Death, 2007
Almudena Porras, Paloma Bragado Domingo, Bragado Paloma   +2 more
exaly  

Comparative effectiveness of cisplatin-based and carboplatin-based chemotherapy for treatment of advanced urothelial carcinoma

Annals of Oncology, 2012
William Oh, Matthew Galsky, Roberto Petrioli   +2 more
exaly  

An integrated view of cisplatin-induced nephrotoxicity and ototoxicity

Toxicology Letters, 2015
Peter Steyger, Takatoshi Karasawa
exaly  

Cisplatin see Vincristine/cisplatin/bleomycin

Reactions Weekly, 1991
openaire   +1 more source

Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies

Kidney International, 2008
exaly  

Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial

Lancet, The, 2016
Conghua Xie, Jianji Pan, Jianping Xiong   +2 more
exaly